COLLEGIUM PHARMACEUTICAL, INC·4

Nov 14, 4:50 PM ET

Karnani Vikram 4

4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Nov 14, 2024

Insider Transaction Report

Form 4
Period: 2024-11-12
Karnani Vikram
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2024-11-12+105,972105,972 total
  • Award

    Stock Option (Right to Purchase)

    2024-11-12+130,344130,344 total
    Exercise: $31.41Exp: 2034-11-12Common Stock (130,344 underlying)
Footnotes (2)
  • [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on November 12, 2025, with the balance vesting in three annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
  • [F2]Twenty-five percent (25%) of the option shall vest and become exercisable on November 12, 2025, with the balance vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES